US Patent Issued to Trellis Bioscience on March 11 for "Immunogen providing an extended protective lifetime against respiratory syncytial virus (RSV) and vaccines thereof" (California Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,246,063, issued on March 11, was assigned to Trellis Bioscience Inc. (Redwood City, Calif.).

"Immunogen providing an extended protective lifetime against respiratory syncytial virus (RSV) and vaccines thereof" was invented by Milton J. Friedman (Alameda, Calif.) and Lawrence M. Kauvar (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Improvements to vaccines against RSV include G protein CCD portions complexed with mAb that block interaction with CX3C-R and modified forms of mAb to prolong serum half-life, as well as inhalable vaccines."

The patent was filed on Feb. 5, 2021, under Application No. 17/168,553.

*For further information, incl...